NCT05318586

Brief Summary

Stroke is of high morbidity and mortality, and surviving patients are often unable to take care of themselves because of severe motor dysfunction. The brain has plasticity, and makes adaptive changes after stroke, resulting in the reorganization and compensation of neural networks. However, the muscle tone of some patients will significantly increase during the recovery process, which affects the rehabilitation effect. Neuromodulation techniques such as repetitive transcranial magnetic stimulation (rTMS) have been widely used to promote brain network remodeling after stroke. The investigators attempted to evaluate the motor brain network characteristics of spastic patients by fNIRS, and used the most active brain regions as rTMS stimulation regions to evaluate the improvement effect of this individualized treatment on post-stroke spasticity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 8, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

April 10, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

April 20, 2022

Status Verified

March 1, 2022

Enrollment Period

1.4 years

First QC Date

March 29, 2022

Last Update Submit

April 18, 2022

Conditions

Keywords

StrokeSpasticity, MuscleRehabilitationfNIRSrTMSActivationBrain network

Outcome Measures

Primary Outcomes (1)

  • modified Ashworth scale

    The range is 0-Ⅳ level, the higher the level, the higher the spasticity.

    1 month

Secondary Outcomes (5)

  • Fugl-Meyer Assessment of upper limb motor function

    1 month

  • Barthel index

    1 month

  • average weighted clustering coefficient

    1 month

  • global efficiency

    1 month

  • inter-density

    1 month

Study Arms (2)

Individualized rTMS based on fNIRS

EXPERIMENTAL

Low-frequency rTMS will be given to the most active brain regions assessed by fNIRS.

Procedure: individual rTMS based on fNIRS

Traditional rTMS strategy

ACTIVE COMPARATOR

The control group will always be given low-frequency rTMS to contralesional M1

Procedure: Traditional rTMS strategy

Interventions

The rTMS parameters will be set according to fNIRS results.

Individualized rTMS based on fNIRS

The low-frequency rTMS to contralesional M1 will always be used.

Traditional rTMS strategy

Eligibility Criteria

Age40 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 40-79 years;
  • Patients with first-onset stroke within 1 to 3 months after onset;
  • Consciousness, sitting balance level 1 or above, can cooperate with fNIRS assessment;
  • The patient or its authorized agent signs the informed consent form.

You may not qualify if:

  • Previous seizures;
  • Suffered from mental illness such as depression, anxiety, mania, and schizophrenia before the stroke onset;
  • Patients with metal on the head, cochlear implants, intracranial infections, etc. who are not suitable for rTMS.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, 710000, China

RECRUITING

MeSH Terms

Conditions

StrokeMuscle Spasticity

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2022

First Posted

April 8, 2022

Study Start

April 10, 2022

Primary Completion

September 1, 2023

Study Completion

December 31, 2023

Last Updated

April 20, 2022

Record last verified: 2022-03

Locations